Related content

Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression

By              

Experimental and Therapeutic Medicine, Vol. 3, Iss. 1, 2012-01 ,pp. : 129-133

Spandidos Publications

Access to resources Recommend Favorite

Analysis of the expression levels of survivin and VEGF in patients with acute lymphoblastic leukemia

By Yang Man   Liu Yongqiang   Lu Shufang   Wang Zhifen   Wang Ran   Zi Youmei   Li Jingdong  

Experimental and Therapeutic Medicine, Vol. 5, Iss. 1, 2013-01 ,pp. : 305-307

Spandidos Publications

Access to resources Recommend Favorite

Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil

By Oliveira L.  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1254-1259

Humana Press, Inc

Access to resources Recommend Favorite

Immunophenotype and increased presence of CD4+CD25+ regulatory T cells in patients with acute lymphoblastic leukemia

By          

Oncology Letters, Vol. 3, Iss. 2, 2012-01 ,pp. : 421-424

Spandidos Publications

Access to resources Recommend Favorite

Prognostic value of the expression of phosphatase and tensin homolog and CD44 in elderly patients with refractory acute myeloid leukemia

By          

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 103-110

Spandidos Publications

Access to resources Recommend Favorite